Ohio State University (OSU) is a clinical research site located in Columbus, Ohio, United States 43210.
Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.
Ohio State University (OSU) has participated in 2 clinical trials.
Therapeutic areas: Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease.
Sponsors: Neurocrine Biosciences, NYU Langone Health.
Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Ohio State University (OSU) has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Ohio State University (OSU) has 2 clinical trials on record. Their work covers Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease.
Ohio State University (OSU) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.